Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis
Authors
Keywords
-
Journal
ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Volume 51, Issue 1, Pages 77-86
Publisher
Wiley
Online
2017-10-21
DOI
10.1002/uog.18934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
- (2017) Isaac Kim et al. Journal of Breast Cancer
- Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis
- (2016) Cristina Silva et al. HUMAN REPRODUCTION
- Appraising the Biological Evidence for and Against the Utility of GnRHa for Preservation of Fertility in Patients With Cancer
- (2016) Kutluk Oktay et al. JOURNAL OF CLINICAL ONCOLOGY
- No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial
- (2016) Isabelle Demeestere et al. JOURNAL OF CLINICAL ONCOLOGY
- Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer
- (2016) Rodrigo R. Munhoz et al. JAMA Oncology
- Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise
- (2016) Reza Soleimani et al. Aging-US
- Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival
- (2015) Matteo Lambertini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
- (2015) Halle C.F. Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protecting Ovaries During Chemotherapy Through Gonad Suppression
- (2015) Eman Elgindy et al. OBSTETRICS AND GYNECOLOGY
- Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
- (2015) Yan Wei Shen et al. OncoTargets and Therapy
- Gonadatrophin Suppression to Prevent Chemotherapy-Induced Ovarian Damage
- (2015) Eman A. Elgindy et al. OBSTETRICS AND GYNECOLOGY
- Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?
- (2014) Jiyoung Kim et al. BREAST
- Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis
- (2014) Wendy S. Vitek et al. FERTILITY AND STERILITY
- Protection of ovarian function by GnRH agonists during chemotherapy: A meta-analysis
- (2014) XIAOMEI SUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study
- (2014) FRANCESCO RECCHIA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Assessment of Periodic Blood Loss: Interindividual and Intraindividual Variations of Pictorial Blood Loss Assessment Chart Registrations
- (2014) Kirsten Hald et al. Journal of Minimally Invasive Gynecology
- Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: A meta-analysis of randomized controlled trials
- (2013) Bo Yang et al. BREAST
- Fertility issues in cancer survivorship
- (2013) Jonathan D. Kort et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials
- (2013) Lucia Del Mastro et al. CANCER TREATMENT REVIEWS
- Effect of leuprolide acetate on ovarian function after cyclophosphamide–doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial
- (2013) Guiping Song et al. MEDICAL ONCOLOGY
- Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
- (2012) Pamela N. Munster et al. JOURNAL OF CLINICAL ONCOLOGY
- Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized Trial
- (2012) Isabelle Demeestere et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer
- (2011) Joseph M. Letourneau et al. CANCER
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Effect of Luteinizing Hormone–Releasing Hormone Agonist on Ovarian Function After Modern Adjuvant Breast Cancer Chemotherapy: The GBG 37 ZORO Study
- (2011) Bernd Gerber et al. JOURNAL OF CLINICAL ONCOLOGY
- No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group
- (2010) K. Behringer et al. ANNALS OF ONCOLOGY
- Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis
- (2010) Irit Ben-Aharon et al. BREAST CANCER RESEARCH AND TREATMENT
- Toxicity of Chemotherapy and Radiation on Female Reproduction
- (2010) DROR MEIROW et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity
- (2010) S. SAMUEL KIM et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis
- (2010) Mohamed A. Bedaiwy et al. FERTILITY AND STERILITY
- Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
- (2009) A. Sverrisdottir et al. BREAST CANCER RESEARCH AND TREATMENT
- GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients
- (2009) Hyun Jung Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
- (2009) Megan E.B. Clowse et al. JOURNAL OF WOMENS HEALTH
- Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study
- (2008) Ahmed Badawy et al. FERTILITY AND STERILITY
- Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin’s disease
- (2008) Foad Azem et al. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
- Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma
- (2007) Zeev Blumenfeld et al. FERTILITY AND STERILITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started